Insulin Price More Than Doubled in the United States
Insulin spending rose from about $2,900 in 2012 to about $5,700 in 2016
Poor Glycemic Control in Type 1 Diabetes Tied to Fracture Risk
Fracture risk up with T2DM and current use of rosiglitazone, pioglitazone regardless of glycemic control
Radiographic Knee Osteoarthritis Tied to Increased Risk for Death
Risk higher for cardiovascular disease, diabetes, renal mortality; lower risk for cancer mortality
Oral Hepatoselective Glucokinase Activator Promising in T2DM
Clinically significant and sustained reduction in glycated hemoglobin was observed with TTP399
Trained Alert Dogs Can Detect Impending T1DM-Related Events
In study, individual dogs' performance varied for detecting hypoglycemic episodes, hyperglycemia
FDA Panel Has Tie Vote on New Type 1 Diabetes Drug
Zynquista is a once-daily pill meant to help type 1 diabetes patients manage their blood glucose levels
Ertugliflozin Seems Safe, Effective for Type 2 Diabetes Treatment
Improvements seen in HbA1c, fasting glucose, body weight, blood pressure over two years
Hemochromatosis Mutation Linked to Other Morbidity
Higher rates of at least one incident-linked condition seen in men, women with HFE p.C282Y homozygosity
Achieving Healthy Diet From Sustainable Food Feasible
Global adoption of healthy reference diet would reduce morbidity, environmental degradation
FDA Down to 5 Weeks of Funding to Review New Drug Applications
Agency cannot accept new fees or applications until the shutdown is over
